Merck & Co. Inc. buy Guggenheim
Start price
12.02.25
/
50%
€83.40
Target price
12.02.26
€110.77
Performance (%)
2.77%
Price
21.11.25
€84.90
Summary
This prediction is currently active. With a performance of 2.77%, the BUY prediction by Guggenheim for Merck & Co. Inc. is trending in the right direction. Dividends of €0.81 are taken into consideration when calculating the performance. This prediction currently runs until 12.02.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 6.125% | 6.125% |
| iShares Core DAX® | -2.673% | -4.643% |
| iShares Nasdaq 100 | -2.173% | -2.819% |
| iShares Nikkei 225® | -3.367% | -3.195% |
| iShares S&P 500 | -1.015% | -1.118% |
Comments by Guggenheim for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Guggenheim from $122.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
Stopped prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€68.70
17.04.25
17.04.25
€101.20
17.04.26
17.04.26
23.58%
21.11.25
21.11.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.60
06.11.24
06.11.24
€121.00
06.11.25
06.11.25
-21.04%
07.11.25
07.11.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24